Back
Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020

Intro
The Hurun Research Institute today released the Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020.

Drug company Hengrui Medicine heads up Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020 with US$53.1bn valuation

 

Shenzhen-based life support device provider Mindray 2nd with US$41.6bn

 

R&D service provider WuXi AppTec 3rd with US$25bn and integrated health system provider AliHealth 4th with US$23.1bn

 

14 companies worth US$10bn or more

 

Drug cos led the way with 62, followed by producers of medical devices and medical services

 

Coronavirus Impact. Disposable medical supplies company Allmed doubled in value in Feb; Ventilator device provider Yuyue rose 62%.

 

Shanghai and Beijing led, with 14 and 12, followed by Hangzhou, Shenzhen, Guangzhou and Chengdu. Others in the Top 10 included Nanjing, Suzhou, Tianjin, Shijiazhuang and Zhuhai. The Top 10 cities accounted for 60% of the companies on the list.

 

World’s most valuable healthcare co is Johnson & Johnson at US$350bn

 

Hurun Research Institute today released the Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020


配图.jpg

 

(18 March 2020, Shanghai, China and Oxford, UK) The Hurun Research Institute today released the Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020, a list of the 100 Chinese privately-controlled enterprises from the healthcare sector, ranked by their market value. ‘Chinese private enterprises’ here refers to non-state-controlled enterprises with headquarters in mainland China. The market value of listed companies is calculated based on the closing price of 28 February 2020. The valuation of non-listed companies is estimated with reference to listed companies from the same industry. This is the first time Hurun Research has released this list.

 

The average value of the Top 100 was US$6.5bn, with the cut-off to make the list US$2.1bn.

 

Rupert Hoogewerf, chairman and chief researcher of Hurun Report, said: “Coronavirus has thrown the spotlight onto China’s top healthcare companies. Six companies from the Hurun Top 100 saw their share price up by half between January 20 and February 28, led by medical product business Allmed, which doubled in value, and followed by respiration equipment provider Yuyue, which rose 62%. Expect to see some of these companies continue to grow as the virus spreads around the world.”

 

“Healthcare in China has surged over the past decade, driven in large part by increased R&D investments. China’s top healthcare companies are now worth five times that of five years ago. Interestingly, no companies doing traditional Chinese medicine made the Top 10 this year.”

 

“China's privately-controlled healthcare companies are much more valuable than their state-controlled counterparts. The largest state-controlled healthcare business, TCM investment platform Changchun High & New Technology Industries, currently valued at US$13.8bn, would not have made the Top 10,” said Hoogewerf.

 

“Quality companies should focus on value creation, not just sales figures. Hengrui Medicine, for example, had revenues of US$3bn last year, but a market value of close to US$60bn.  Retail pharmacy stores business Shanghai Pharmaceuticals by contrast had revenues of almost US$30bn but a market cap of ‘only’ US$7bn."

 

Healthcare is the third largest industry for non-state controlled companies in China, after manufacturing and real estate. 66 companies made it to the Hurun China 500 Most Valuable Private Companies 2019, released in early January.

 

 

This is a brief English language summary of the full Chinese press release which can be found at www.hurun.net. For media enquiries please contact our public relations team whose contact details can be found at the end of this report.

 

 


Top Ten – Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020

 

In the Top 10, Lianyungang, Shanghai and Beijing has the most companies with 2. The cut-off to make the Top 10 was US$14.3bn.

 


Corporation

Co Value US$bn

Sub sector

Headquarters

1

Hengrui   Medicine

53.1

Life Sciences

Lianyungang

2

Mindray

41.6

Medical equipment

Shenzhen

3

WuXi   AppTec

25.0

Life Sciences

Shanghai

4

AliHealth

23.1

Health Tech

Beijing

5

Yangtze   River Pharmaceutical Group

20.7

Life Sciences

Taizhou

6

Hansoh   Pharmaceutical

20.1

Life Sciences

Lianyungang

7

WuXi   Biologics

19.0

Life Sciences

Shanghai

8

Sino Biopharmaceutical

18.3

Life Sciences

Beijing

9

AIER Eye   Hospital Group

17.7

Medical Services

Changsha

10

CSPC   Pharmaceutical Group

14.3

Pharmaceutical   Industry

Shijiazhuang

SourceHurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020

 

Hengrui Medicine is the most valuable private healthcare enterprise with a market value of US$53.1bn. They have applied for 650 domestic patents, possess 140 domestically-authorized patents, and 200 patents in Europe, America and Japan. Hengrui Medicine's operating income in the first three quarters of last year was US$2.4bn, an increase of 36% year-on-year with net profit US$563mn, up 28%.

 

Mindray Bio-Medical Electronics was second with a market value of US$41.6bn. Set-up in 1991, Mindray has become China's largest supplier of medical devices, sold today across most of the world. Its main products include patient monitoring & life support products, including ventilators, defibrillators, ECG machines, pulse oxymeters and hospital beds.

 

WuXi AppTec ranked 3rd with a market value of US$25bn. Established in December 2000, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients.  60% of its 23,000 employees have phd’s.

 

AliHealth ranked 4th with a market value of US$23.1bn. AliHealth is a comprehensive online medical platform. AliHealth is mainly engaged in medical e-commerce business, and is also actively exploring Internet medical and smart medical related business, using information technology, AI and big data technology to help offline institutions improve operational efficiency and service experience.

 

Yangtze River Pharmaceutical Group ranked 5th with a market value of US$20.7bn. Founded in 1971 Yangtze River Pharmaceutical Group's main products include both Chinese and Western medicines, and both prescription and non-prescription medicines. It has formed more than 10 series including cardio-cerebral vascular drugs, antimicrobial drugs, digestive system drugs, antitumor drugs, antipyretic and analgesics, etc., covering more than 20 dosage forms and more than 200 product specifications.

 

Hansoh Pharmaceutical ranked 6th with a market value of US$20.1bn. The company has established a leading position in some of China's largest and fastest-growing therapeutic areas with significant unmet clinical needs, including central nervous system disease, antitumor, anti-infection and diabetes.

 

WuXi Biologics ranked 7th with a market value of US$19bn. The company was founded in 2010 and initially provided customers with cell line incubation and protein analysis services. After several years of development, the company's business has expanded to new biological drug discovery, new biological drug development, biological testing and GMP production. With high-standard production bases around the world and a strong scientific research team, WuXi Biologics has grown into an open biopharmaceutical technology platform company providing one-stop services from concept to commercial. In 2017, WuXi Biologics was listed on the Hong Kong Stock Exchange.

 

Sino Biopharmaceutical ranked 8th with a market value of US$18.3bn. The group's business covers the entire industrial chain of various pharmaceutical R&D platforms, intelligent production and a strong sales system. Its products include a variety of biological drugs and chemical drugs, and it is in an advantageous position in many promising therapeutic fields such as tumors, liver diseases, respiratory drugs, analgesics, cardiovascular and cerebrovascular diseases, orthopedic diseases.

 

Aier Eye Hospital Group ranked 9th with a market value of US$17.7bn. Aier was listed in 2009, when it had a market value of only US$1bn.

 

CSPC Pharmaceutical Group ranked 10th with a market value of US$14.3bn. CSPC originally produced APIs. In 1999, they obtained a national patent for a new class of drugs, butylphthalide. Butylphthalide was put on the market in 2005. CSPC has gradually evolved from an API manufacturer to an innovative drug manufacturer. The main products include vitamins, antibiotics, innovative drugs, brand drugs and generic drugs.

 

Compared with 5yrs and 10yrs ago

Five and ten years ago, there were traditional Chinese medicine companies in the Top 10 such as Guilin Sanjin Pharmaceutical and Jointown Pharmaceutical Group.  Today there are no TCM companies in the Top 10.

 

Top 10 five years ago


Top 10 ten years ago


Corporation

Co Value US$bn



Corporation

Co Value US$bn

1

Shanghai RAAS

9.3


1

Hengrui Medicine

4.2

2

Hengrui Medicine

8.8


2

WEGO Group

3.8

3

Fosun Pharma

7.1


3

Fosun Pharma

3.5

4

Tasly Pharmaceutical Group

6.4


4

Hualan   Biological Engineering

2.9

5

Sihuan Pharmaceutical

5.2


5

NHU

2.1

6

Jointown   Pharmaceutical Group

5.1


6

Zhejiang Pharmaceutical

2.0

7

AliHealth

4.9


7

Joincare   Pharmaceutical

1.9

8

CSPC   Pharmaceutical Group

4.1


7

Tasly Pharmaceutical Group

1.9

8

Sino   Biopharmaceutical

4.1


7

Guilin Sanjin Pharmaceutical

1.9

10

Salubris   Pharmaceuticals

3.5


10

Salubris   Pharmaceuticals

1.5

Source: Hurun Research Institute



Top Ten Most Valuable Healthcare Companies in the World 2020

Six of the Top 10 most valuable healthcare businesses in the world are from the USA, followed by Switzerland with 2 and one from each of Ireland and Denmark.

 


Corporation

Value US$bn

 Headquarters

1

Johnson &   Johnson

350

USA

2

UnitedHealth   Group

240

USA

3

Roche Holding

224

Switzerland

4

Merck &   Co

194

USA

5

Novartis

190

Switzerland

6

Pfizer

186

USA

7

Novo Nordisk

140

Denmark

8

Abbott   Laboratories

136

USA

9

Medtronic

134

Ireland

10

AbbVie

130

USA

Source: Hurun Research Institute

 


Top Five Most Valuable Non-State-Controlled Insurance Companies in China

Hoogewerf said, “Insurance companies have been playing a key role in the development of China’s healthcare sector, led by the likes of Ping An and Taikang.”

 


Corporation

Co Value US$bn

Headquarters

Chairperson

1

Ping An Insurance

200

Shenzhen

Ma Mingzhe

2

Taikang Insurance

30.8

Beijing

Chen Dongsheng

3

Sunshine Insurance Group

6.2

Shenzhen

Zhang Weigong

4

Zhongan Insurance

6.1

Shanghai

Ou Yaping

5

Foresea Life Insurance

3.4

Shenzhen

Zhang Jinshun

Source: Hurun Research Institute

 

 

Investment into R&D

The Top 10 spent approximately 10% on R&D investment, led by Hengrui Medicine with 15%.

 

 

Geographic Distribution

By city, Shanghai and Beijing led the way with 14 and 12, followed by Hangzhou and Shenzhen. By province, Guangdong was top with 16 companies on the list, followed by Zhejiang and Shanghai ranked 2nd. Beijing ranked 4th with 12 and Jiangsu ranked 5th with 11.

 

 


Headquarters by province

No. of companies



Headquarters by city

No. of companies

1

Guangdong

16


1

Shanghai

14

2

Shanghai

14


2

Beijing

12

2

Zhejiang

14


3

Shenzhen

9

4

Beijing

12


3

Hangzhou

9

5

Jiangsu

11


5

Guangzhou

4

6

Hubei

4


5

Chengdu

4

6

Sichuan

4


7

Zhuhai

3

8

Hebei

3


7

Shijiazhuang

3

8

Hunan

3


7

Nanjing

3

8

Jilin

3


7

Suzhou

3

8

Jiangxi

3


7

Tianjin

3

8

Tianjin

3


12

Hefei

2

13

Anhui

2


12

Wuhan

2

13

Henan

2


12

Changsha

2

13

Shandong

2


12

Lianyungang

2

16

Fujian

1


12

Nanchang

2

16

Hainan

1


12

Taizhou

2

16

Liaoning

1





16

Shaanxi

1





16

Tibet

1





16

Yunnan

1





SourceHurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020

 

 

Which industries did best?

Drug cos led the way with 62, followed by producers of medical devices and medical services.

 


Industries

No. of Cos

Representative Companies

1

Drug companies

62

Hengrui Medicine, WuXi AppTec, Yangtze River Pharmaceutical Group, Hansoh   Pharmaceutical, WuXi Biologics, Sino Biopharmaceutical, CSPC Pharmaceutical   Group

2

Medical devices

17

Mindray Bio-Medical Electronics, Lepu Medical Technology, WEGO Group

3

Medical services

15

Aier Eye Hospital, Evergrande Health, Health 100

4

Health Tech

5

AliHealth, Ping An Healthcare And Technology, Ping An Healthcare Technology

5

Genomics

2

Antobio, BGI Genomics

5

Vaccinations

2

Zhifei Biological, CanSinoBIO

SourceHurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020

 

 

Coronavirus impact on valuations

Between 20 January, when the coronavirus hit the markets in China and 28 February, the cut-off date for the Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020, the market value of some healthcare companies grew significantly.

 

Medical product business Allmed saw its share price double in this period, as demand for its products shot through the roof. Respiration equipment provider Yuyue rose 62%.

 


Corporation

Market value increase from   20 Jan to 28 Feb 2020

Company Value US$bn

1

Allmed Medical Products

92%

3

2

Yuyue Medical   Equipment And Supply

62%

5

3

Winning Health   Technology

57%

6

4

AliHealth

51%

23.1

5

BrightGene   Bio-Medical Technology

48%

3.7

6

Neptunus   Bioengineering

46%

2.3

7

Blue Sail Medical

40%

2.4

8

AK Medical Holdings

31%

2.1

9

CanSinoBIO

28%

2.3

10

Kinetic Medical

27%

2.1

Source: Hurun Research Institute

 


About Hurun Report Inc.

Promoting Entrepreneurship through Quality Lists and Research

Hurun Report generated 300 million views globally on average every month last year, through putting out lists and research.

 

Established in 1999 by British accountant Rupert Hoogewerf, Hurun Report Inc. has grown into a leading research platform based in Shanghai and Mumbai, best-known for its China and India rich lists, and with 150 employees today.

 

Hurun Research Institute ‘World’s Largest Rich List Provider’

2020 marks the 21st anniversary of Hurun Report, highlighting the fastest wealth creating period in the history of the world.

 

The Hurun Richest Self-Made Women in the World has been highlighting for over ten years the fact that over 70% of the world’s most successful women in business herald from China, ie Chinese are completely dominant in the world of women in business. This has changed the way the world looks at Chinese women in business.

 

The Hurun China Philanthropy List ranks the most generous individuals in China and is now in its 15th anniversary.  With no inheritance tax, Chinese give much more generously than many have previously understood.

 

Two recent lists with an impact include the Hurun China Unicorn Index, ranking the most dynamic businesses with a valuation of US$1bn or more in China; and the Hurun Most Successful University Alumni.

 

In India, Hurun Research has launched the Hurun India Rich List for the seventh time last year, and has an active events business there.

 

‘World Authority on the Chinese High Net Worth Individual’

Recent research partners include financial institutions (PingAn, Bank of China, Taikang Life, Minsheng, Citic), local government (Shanghai, Changbaishan) and Global 500 multinationals (Marriott, Country Garden, Agile, Audi, Volvo).

 

Three breakthrough lists this past year: Hurun Good Doctors’ List, a ranking of the 9500 most respected doctors in China, broken down by region and speciality; Hurun Best International Schools List; and Hurun Creative Works Intellectual Property List, in Search of the Harry Potter of China, ranking those online novels with the most valuable IPs.

 

The Hurun Art List ranks the top artists alive today in China for the 12th year and has become a household name amongst artists.

 

Media and Events

The Hurun brand has become one of the few non-Chinese media brands to become a household name across China.

 

Hurun Media monetizes 2 million views a month in China, through its wechat, weibo, website and legacy magazine.

 

Recent themed events include blockchain, fintech and 30 under 30, with industry-respected awards. We deliver 100+ events a year in China, with 200 entrepreneurs from the Hurun China Rich List attending.

 

Hurun Report kicked off the world's largest Chinese New Year dinner series in Shanghai in 2019 on January 16, and is going to 8 cities across 4 continents. Toronto on Jan 20, New York Jan 23, LA Jan 25, London Jan 28, Istanbul Jan 29, Luxembourg Jan 31 and ending up in Sydney on Feb 18. Hurun Report’s mission is to create the world's largest platform of China gatekeepers.

 

Investments

Hurun Investments has a portfolio of 20 companies with a market value of US$50 million, with investments into tech, media, design, education as well as a vintage car race and a tailor.

 


Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies 2020

 

Rank

Corporation

Co Value US$bn

Industry

Headquarters

Headquarters   (City)

1

Hengrui   Medicine

53.1

Drugs

Jiangsu

Lianyungang

2

Mindray   Bio-Medical Electronics

41.6

Medical devices

Guangdong

Shenzhen

3

WuXi AppTec

25.0

Drugs

Shanghai

Shanghai

4

AliHealth

23.1

Health Tech

Beijing

Beijing

5

Yangtze River   Pharmaceutical

20.7

Drugs

Jiangsu

Taizhou

6

Hansoh   Pharmaceutical

20.1

Drugs

Jiangsu

Lianyungang

7

WuXi Biologics

19.0

Drugs

Shanghai

Shanghai

8

Sino   Biopharmaceutical

18.3

Drugs

Beijing

Beijing

9

AIER Eye   Hospital Group

17.7

Medical   Services

Hunan

Changsha

10

CSPC Pharmaceutical

14.3

Drugs

Hebei

Shijiazhuang

11

Zhifei   Biological

13.7

Vacinations

Chongqing

Chongqing

12

BeiGene

11.9

Drugs

Beijing

Beijing

13

PingAn Good   Doctors

10.4

Health Tech

Shanghai

Shanghai

14

Kangtai   Biological Products

10.3

Drugs

Guangdong

Shenzhen

15

Fosun Pharma

9.3

Drugs

Shanghai

Shanghai

16

Lepu Medical   Technology

8.7

Medical devices

Beijing

Beijing

17

Ping An   Healthcare Technology

8.6

Health Tech

Shanghai

Shanghai

18

Hualan   Biological Engineering

8.3

Drugs

Henan

Xinxiang

19

Tigermed

8.1

Drugs

Zhejiang

Hangzhou

20

Evergrande   Health

8.0

Medical   Services

Guangdong

Guangzhou

21

Health 100

7.4

Medical   Services

Shanghai

Shanghai

21

NHU

7.4

Drugs

Zhejiang

Shaoxing

21

Antobio

7.4

Genomics

Henan

Zhengzhou

24

JD Health

6.9

Health Tech

Beijing

Beijing

25

Shanghai RAAS

6.4

Drugs

Shanghai

Shanghai

26

Pharmaron

6.3

Drugs

Beijing

Beijing

26

Walvax   Biotechnology

6.3

Drugs

Yunnan

Kunming

28

Innovent   Biologics

6.1

Drugs

Jiangsu

Suzhou

29

Winning Health   Technology

6.0

Medical   Services

Shanghai

Shanghai

30

WEGO Group

5.9

Medical devices

Shandong

Weihai

30

Bloomage   Biotechnology

5.9

Drugs

Beijing

Beijing

30

Asymchem   Laboratories

5.9

Drugs

Tianjin

Tianjin

33

Wedoctor

5.6

Health Tech

Zhejiang

Hangzhou

33

Buchang Group

5.6

Drugs

Beijing

Beijing

35

Jafron   Biomedical

5.4

Medical devices

Guangdong

Zhuhai

36

King-Friend   Biochemical Pharmaceutical

5.1

Drugs

Jiangsu

Nanjing

37

United Imaging

5.0

Medical devices

Shanghai

Shanghai

37

Yuyue Medical   Equipment And Supply

5.0

Medical devices

Jiangsu

Zhenjiang

39

Huadong   Medicine

4.9

Drugs

Zhejiang

Hangzhou

39

Jemincare

4.9

Drugs

Jiangxi

Nanchang

41

Top Choice   Medical

4.7

Medical devices

Zhejiang

Hangzhou

41

Kelun   Pharmaceutical

4.7

Drugs

Sichuan

Chengdu

41

BGI Genomics

4.7

Genomics

Guangdong

Shenzhen

44

Betta   Pharmaceutical

4.6

Drugs

Zhejiang

Hangzhou

44

Hepalink   Pharmaceutical

4.6

Drugs

Guangdong

Shenzhen

46

Yifeng Pharmacy   Chain

4.4

Medical   Services

Hunan

Changde

46

China Biologic   Products

4.4

Drugs

Beijing

Beijing

48

Jointown   Pharmaceutical

4.3

Medical   Services

Hubei

Wuhan

48

Livzon   Pharmaceutica

4.3

Drugs

Guangdong

Zhuhai

50

Dashenlin   Pharmaceutical

4.1

Medical   Services

Guangdong

Guangzhou

50

Kanghong   Pharmaceuticals 

4.1

Drugs

Sichuan

Chengdu

52

Zailab

4.0

Drugs

Shanghai

Shanghai

52

Huahai   Pharmaceutical

4.0

Drugs

Zhejiang

Taizhou

54

Double Medical   Technology

3.9

Medical devices

Fujian

Xiamen

54

Genscript 

3.9

Drugs

Jiangsu

Nanjing

56

BrightGene   Bio-Medical Technology

3.7

Drugs

Jiangsu

Suzhou

56

By-Health

3.7

Drugs

Guangdong

Zhuhai

58

Kingmed   Diagnostics

3.6

Medical Services

Guangdong

Guangzhou

58

Xiuzheng

3.6

Drugs

Jilin

Changchun

58

Junshi   Biosciences

3.6

Drugs

Shanghai

Shanghai

61

Micro-Tech

3.4

Medical devices

Jiangsu

Nanjing

61

Yifan Xinfu   Pharmaceutical

3.4

Drugs

Zhejiang

Hangzhou

61

Haisco   Pharmaceutical

3.4

Drugs

Tibet

Shannan

64

Orthok

3.3

Medical devices

Anhui

Hefei

64

Wolwo Pharma

3.3

Drugs

Zhejiang

Huzhou

64

Tasly   Pharmaceutical

3.3

Drugs

Tianjin

Tianjin

64

Tonghua Dongbao   Pharmaceutical

3.3

Drugs

Jilin

Tonghua

68

Wondfo Biotech

3.1

Medical   Services

Guangdong

Guangzhou

68

Jinxin   Fertility

3.1

Medical   Services

Sichuan

Chengdu

68

Joincare   Pharmaceutical

3.1

Drugs

Guangdong

Shenzhen

68

Chipscreen   Biosciences

3.1

Drugs

Guangdong

Shenzhen

72

Allmed Medical   Products

3.0

Medical devices

Hubei

Zhijiang

72

China Medical   System

3.0

Medical   Services

Guangdong

Shenzhen

74

Lbx Pharmacy   Chain

2.9

Medical   Services

Hunan

Changsha

74

Henlius Biotech

2.9

Drugs

Shanghai

Shanghai

74

YanAn Bicon

2.9

Drugs

Shanxi

Yanan

77

Jilin Aodong   Pharmaceutical

2.7

Drugs

Jilin

Dunhua

77

Salubris   Pharmaceuticals

2.7

Drugs

Guangdong

Shenzhen

77

Yiling   Pharmaceutical

2.7

Drugs

Hebei

Shijiazhuang

77

Jumpcan

2.7

Drugs

Jiangsu

Taixing

77

Humanwell   Healthcare

2.7

Drugs

Hubei

Wuhan

77

HEC

2.7

Drugs

Hubei

Yidu

83

3Sbio

2.6

Drugs

Liaoning

Shenyang

83

SSY Group

2.6

Drugs

Hebei

Shijiazhuang

85

Maccura   Biotechnology

2.4

Medical devices

Sichuan

Chengdu

85

Venus Medtech

2.4

Medical devices

Zhejiang

Hangzhou

85

MicroPort   Scientific

2.4

Medical devices

Shanghai

Shanghai

85

Blue Sail   Medical

2.4

Medical devices

Shandong

Zibo

85

Poly Pharm

2.4

Drugs

Hainan

Haikou

85

Chimin Health   Management

2.4

Drugs

Zhejiang

Taizhou

91

Dian   Diagnostics

2.3

Medical   Services

Zhejiang

Hangzhou

91

Neptunus   Bioengineering

2.3

Medical   Services

Guangdong

Shenzhen

91

Conba   Pharmaceutical

2.3

Drugs

Zhejiang

Hangzhou

91

Anke   Biotechnology

2.3

Drugs

Anhui

Hefei

91

Jiuzhou   Pharmaceutical

2.3

Drugs

Zhejiang

Taizhou

91

CanSinoBIO

2.3

Vacinations

Tianjin

Tianjin

97

Ak Medical   Holdings

2.1

Medical devices

Beijing

Beijing

97

Kinetic Medical

2.1

Medical devices

Shanghai

Shanghai

97

Cowell Health

2.1

Medical   Services

Beijing

Beijing

97

Grand   Pharmaceutical and Healthcare

2.1

Drugs

Beijing

Beijing

97

Boya   Bio-pharmaceutical

2.1

Drugs

Jiangxi

Fuzhou

97

Renhe Pharmacy

2.1

Drugs

Jiangxi

Nanchang

97

Alphamab   Oncology

2.1

Drugs

Jiangsu

Suzhou



Download:

Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies ENG&CHN 200318.xlsx

新闻稿:《2020胡润中国百强大健康民营企业》200318.docx

Hurun China 100 Most Valuable Non-State-Controlled Healthcare Companies ENG 200318.docx 

Keywords:Most Valuable Non-State-Controlled Healthcare Companies
Editor:Porsha Pan